[go: up one dir, main page]

FI924368A0 - Expression av heterologiskt protein i jaest. - Google Patents

Expression av heterologiskt protein i jaest.

Info

Publication number
FI924368A0
FI924368A0 FI924368A FI924368A FI924368A0 FI 924368 A0 FI924368 A0 FI 924368A0 FI 924368 A FI924368 A FI 924368A FI 924368 A FI924368 A FI 924368A FI 924368 A0 FI924368 A0 FI 924368A0
Authority
FI
Finland
Prior art keywords
expression
jaest
heterologiskt
protein
antigens
Prior art date
Application number
FI924368A
Other languages
English (en)
Other versions
FI924368L (fi
FI104981B (fi
Inventor
Jeffrey John Clare
Michael Anthony Romanos
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10673740&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI924368(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI924368L publication Critical patent/FI924368L/fi
Publication of FI924368A0 publication Critical patent/FI924368A0/fi
Application granted granted Critical
Publication of FI104981B publication Critical patent/FI104981B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI924368A 1990-04-02 1992-09-29 Menetelmä pertaktiiniantigeenin tuottamiseksi ja sitä ilmentävä Pichia-mikro-organismi FI104981B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9007416 1990-04-02
GB909007416A GB9007416D0 (en) 1990-04-02 1990-04-02 Expression of heterologous protein in yeast
GB9100487 1991-03-28
PCT/GB1991/000487 WO1991015571A1 (en) 1990-04-02 1991-03-28 Expression of heterologous protein in yeast

Publications (3)

Publication Number Publication Date
FI924368L FI924368L (fi) 1992-09-29
FI924368A0 true FI924368A0 (fi) 1992-09-29
FI104981B FI104981B (fi) 2000-05-15

Family

ID=10673740

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924368A FI104981B (fi) 1990-04-02 1992-09-29 Menetelmä pertaktiiniantigeenin tuottamiseksi ja sitä ilmentävä Pichia-mikro-organismi

Country Status (12)

Country Link
EP (2) EP0527752B1 (fi)
JP (1) JP3510624B2 (fi)
AT (1) ATE180013T1 (fi)
CA (1) CA2078858C (fi)
DE (1) DE69131226T2 (fi)
DK (1) DK0527752T3 (fi)
ES (1) ES2133284T3 (fi)
FI (1) FI104981B (fi)
GB (1) GB9007416D0 (fi)
GR (1) GR3030632T3 (fi)
NO (1) NO310150B1 (fi)
WO (1) WO1991015571A1 (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
GB8910570D0 (en) 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
US6197548B1 (en) 1990-04-02 2001-03-06 Medeva Pharma Limited Transformed Pichia expressing the pertactin antigen
GB9007657D0 (en) † 1990-04-04 1990-05-30 Connaught Lab Purification of a pertussis outer membrane protein(omp69)
GB9027901D0 (en) * 1990-12-21 1991-02-13 Wellcome Found Acellular vaccine
GB9106568D0 (en) * 1991-03-27 1991-05-15 Wellcome Found Recombinant antigen
US6444211B2 (en) 1991-04-03 2002-09-03 Connaught Laboratories, Inc. Purification of a pertussis outer membrane protein
GB9402832D0 (en) * 1994-02-15 1994-04-06 Smith Kline Beecham Biolog S A Novel process
PT1035133E (pt) 1999-02-17 2005-05-31 Pfizer Prod Inc Proteinas de fusao compreendendo veiculos que podem induzir uma dupla resposta imune
ATE393166T1 (de) * 2000-05-25 2008-05-15 Pasteur Institut Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen
EP1174505A1 (en) * 2000-06-30 2002-01-23 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur (Poly)peptides for the preparation of vaccines against Bordetella pertussis and/or Bordetella parapertussis, vaccines based upon such (poly)peptides, and antibodies against such peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ228948A (en) * 1988-05-13 1991-06-25 Phillips Petroleum Co Hbv particles containing s and pre-s 2 proteins and recombinant processes for their production in yeast cells

Also Published As

Publication number Publication date
GB9007416D0 (en) 1990-05-30
ATE180013T1 (de) 1999-05-15
FI924368L (fi) 1992-09-29
DE69131226D1 (de) 1999-06-17
DE69131226T2 (de) 1999-09-23
CA2078858C (en) 2001-05-15
ES2133284T3 (es) 1999-09-16
DK0527752T3 (da) 1999-11-01
NO923781D0 (no) 1992-09-29
CA2078858A1 (en) 1991-10-03
NO923781L (no) 1992-09-29
GR3030632T3 (en) 1999-10-29
NO310150B1 (no) 2001-05-28
EP0527752A1 (en) 1993-02-24
JP3510624B2 (ja) 2004-03-29
WO1991015571A1 (en) 1991-10-17
EP0905251A1 (en) 1999-03-31
FI104981B (fi) 2000-05-15
JPH05505725A (ja) 1993-08-26
EP0527752B1 (en) 1999-05-12

Similar Documents

Publication Publication Date Title
DK0733069T3 (da) Oprensede Primat CTLA-8-antigener og beslægtede reagenser
CA2114015A1 (en) Recombinant antibodies for human therapy
DK187889D0 (da) Dna-forbindelser og klonende vektorer, der koder for det monoklonale antistof ks1/4, samt chimere antistoffer afledt af ks1/4 og rettet mod et humant adenocarcinoma-antigen
EP0739980A3 (en) CD 19 coding DNA
FI924368A0 (fi) Expression av heterologiskt protein i jaest.
FI934135A0 (fi) Ett foerfarande foer framstaellning av heme-proteiner
ATA192895A (de) Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
DE68918673D1 (de) IgG-bindendes Protein H, kodierendes Gen dafür und Verfahren zu seiner Herstellung.
DK346385A (da) Genetiske sekvenser, hermed kodede interferon-peptider af type i og organismer, der producerer disse
DE69018926D1 (de) Vakzine gegen Bordetella.
AU8298991A (en) Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins
EP0619324A4 (en) Human type antibody reactive with gpiib/iiia.
ATE162553T1 (de) Monoklonale antikörper gegen hepatitis-c-virus
DK0442372T3 (da) Forbedrede mærkede haptener, fremgangsmåde til deres fremstilling samt anvendelse af disse mærkede haptener ved immunoassays
EP0299354A3 (en) Monoclonal antibodies against protein e7 of the human papilloma virus type 16, their production process and their use
ATE280229T1 (de) Enterotoxine von shigella flexneri 2a
DE3885975D1 (de) Monoklonale Antikörper gegen menschliche alpha-Atrialnatriüretic-Polypeptide und entsprechende Hybridome, deren Herstellung und Verwendung.
ATE103973T1 (de) Gamma-atriales, natriuretisches polypeptid erkennende monoklonale antikoerper, solche antikoerper produzierende hybridome und deren herstellung und verwendung.
ES2165358T3 (es) Utilizaciones de la proteinquinasa de neurofilamento/tau pk40.
DE69021921D1 (de) Monoklonale Antikörper gegen den C-Terminus von ANP.
GR3014977T3 (en) Monoclonal antibody against endothelin, hybridoma capable of producing the same and radioimmunoassay for endothelin by using the same.
ITFI920071A0 (it) Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vogeesndk
DE69132647D1 (de) Monomere zur Verwendung von fluorierten Polychinolinen
DE69128095D1 (de) Azelluläre impfstoffe
JPS5382434A (en) Surface covered plastic spectacle lens

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: EVANS MEDICAL LIMITED

MA Patent expired